Dr Jane Smit

Jane has worked in the cancer field over decades in a variety of roles spanning ovarian cancer diagnostics; breast cancer clinical trials; big pharma, biotech and medtech equity research and, institutional life science venture capital.

Jane was a Healthcare Partner with SEP, a leading UK tech VC, and Managing Partner and Global Head of Life Sciences with Dresdner Kleinwort Capital. Before her own cancer diagnosis she was a Senior Advisor to Oxford University spin-out specialists OIC. Jane was one of the UK City’s first top-rated sell-side biotech analysts with biotech pioneer Kleinwort Benson and before that covered the European pharma sector.

As a life sciences’ thought leader, she was involved in many international boards, committees, government, and industry initiatives to support sector growth. Jane has helped to raise funds for many public and private life science companies and cancer charities. She has a PhD (Medical Faculty Scholarship) in immuno-oncology from Edinburgh University. Jane is a breast cancer survivor with a high familial cancer burden and rare genetic link. She was an early advocate of biomarkers for precision cancer care and is passionate about prevention and equitable access to the highest quality care and timely information.